India weighs red warning labels on cough syrups for children under 4
India is considering mandatory red bottle warnings and child imagery to deter cough-syrup use in children under four. Separately, syrup medicines have lost over-the-counter exemptions, requiring prescriptions and potentially curbing pharmacy sales.
What happened
retail-company · India is considering mandatory red warnings and child imagery on cough syrup bottles to deter use below age four. Separately, syrup medicines
Key facts
- Under 4 years
- Under 2 years
- October 2025
- April 2026
- June 9, 2026
What changed
India is considering mandatory red warnings and child imagery on cough syrup bottles to deter use below age four. Separately, syrup medicines have been removed from over-the-counter exemptions, requiring prescriptions and affecting pharmacy retail sales.
Why this matters
Pharmacies should prepare for lower walk-in cough-syrup sales, prescription-verification workflows, and prominent warning-label compliance for paediatric products.
What to watch
- Final CDSCO or Health Ministry notification defining affected syrup products, age threshold, label language, and effective date.
- State drug-controller enforcement guidance and penalty actions against pharmacies or manufacturers.
- Prescription-rule implementation details, including whether e-prescriptions, repeat prescriptions, and teleconsultation prescriptions are accepted.
- Monthly pediatric cough-syrup sales data, retailer stock-outs, and substitution demand in saline, vapor rub, and herbal or honey-based remedies.
- Any expansion of restrictions to broader pediatric cold-and-cough combinations or tighter rules for online pharmacies.